These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17137250)
21. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597 [TBL] [Abstract][Full Text] [Related]
22. [Galectins in squamous cell carcinomas of the head and neck cancers]. Cada Z; Plzák J; Chovanec M; Dvoránková B; Lacina L; Szabó P; Smetana K; Betka J Cas Lek Cesk; 2008; 147(11):559-63. PubMed ID: 19097359 [TBL] [Abstract][Full Text] [Related]
23. [Molecular epidemiology of cancers and precancerous conditions]. Ember I; Kiss I; Sándor J; Varga C; Gyöngyi Z; Németh K; Fehér K; Lukács P; Dombi Z Orv Hetil; 2004 Mar; 145(10):507-14. PubMed ID: 15085589 [TBL] [Abstract][Full Text] [Related]
24. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000 [TBL] [Abstract][Full Text] [Related]
25. Tissue microarray - a high-throughput molecular analysis in head and neck cancer. Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941 [TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684 [TBL] [Abstract][Full Text] [Related]
28. [Cervical neuroblastoma in an infant]. Arvai K; Tóth J; Németh T; Kiss C; Molnár P; Oláh E Magy Onkol; 2004; 48(1):89-95. PubMed ID: 15105902 [TBL] [Abstract][Full Text] [Related]
29. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications. Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406 [TBL] [Abstract][Full Text] [Related]
30. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827 [TBL] [Abstract][Full Text] [Related]
31. The stem cell hypothesis in head and neck cancer. Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610 [TBL] [Abstract][Full Text] [Related]
32. [Report on the first year of the activity of the National Oncological RD Consortium]. Tímár J Magy Onkol; 2002; 46(4):297-300. PubMed ID: 12563351 [TBL] [Abstract][Full Text] [Related]
33. [Contribution of molecular biology to new diagnostic and/or prognostic markers characterization in cancerogenesis]. de Fraipont F Ann Biol Clin (Paris); 2007; 65(1):21-6. PubMed ID: 17264035 [TBL] [Abstract][Full Text] [Related]
34. New generation of molecular prognostic and predictive tests for breast cancer. Pusztai L; Cristofanilli M; Paik S Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431 [TBL] [Abstract][Full Text] [Related]
35. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival? Almadori G; Bussu F; Paludetti G Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030 [TBL] [Abstract][Full Text] [Related]
36. The use of molecular markers of bone turnover in the management of patients with metastatic bone disease. Seibel MJ Clin Endocrinol (Oxf); 2008 Jun; 68(6):839-49. PubMed ID: 17980010 [TBL] [Abstract][Full Text] [Related]
37. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas. Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726 [TBL] [Abstract][Full Text] [Related]
38. The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review. De Schutter H; Spaepen M; Mc Bride WH; Nuyts S Eur J Hum Genet; 2007 Jul; 15(7):734-41. PubMed ID: 17473833 [TBL] [Abstract][Full Text] [Related]
39. [Coincidental squamous cell cancers of the esophagus and head and neck: risk and surveillance]. Steinberg J; Schwertner C; de Villiers EM; Mir-Salim P; Kiesslich R; Stoelzel U; Scherübl H Z Gastroenterol; 2007 Aug; 45(8):710-4. PubMed ID: 17701861 [TBL] [Abstract][Full Text] [Related]
40. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography. Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]